Galera Therapeutics Inc reports results for the quarter ended in March - Earnings Summary

Galera Therapeutics

16/05/2022 14:10

* Galera Therapeutics Inc  GRTX.OQ  reported a quarterly
adjusted
loss of 58 cents​​ per share for the quarter ended in March. The
mean expectation of three analysts for the quarter was for a
loss of 57 cents per share.
    * Reported revenue was zero​;  analysts expected zero. 
    * Galera Therapeutics Inc's reported EPS for the quarter was
a
loss of 58 cents​.
    * The mean earnings estimate of analysts had risen by
about 22.7%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Galera Therapeutics Inc shares had fallen by 36.6% this
quarter and lost 67.1% so far this year.
    * The company reported a quarterly loss of $15.44 million.
    * Wall Street's median 12-month price target for Galera
Therapeutics Inc is $12.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 16 at 01:10 p.m.  ​All
figures in US dollars unless otherwise stated